Quadrivalent seasonal influenza vaccine

Phase 3Vaccine

Quadrivalent seasonal influenza vaccine is one of 7 biologic programs targeting Vaccine Response. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Vaccine ResponseRecruiting

Vaccine ResponsePhase 3

Recruiting

Competition

Competitive Landscape

7 competitors in Vaccine Response

#DrugCompanyPhaseTrials

Fluzone

GSK

Phase 2

2 2

Quadrivalent seasonal influenza vaccine

EEmory University

Phase 3

2 3

Fluad

Moderna

Phase 2

3 4

Thymalfasin

SSciClone Pharmaceuticals

Phase 1

1 5

Menacwy Liquid

GSK

Preclinical

1 6

PCV-13

UUniversity of Colorado, Denver

Preclinical

1 7

Typhim Vi Vaccine

NNicole Stoffel

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

ApprovedRecruiting

Vaccine Response

NCT05801978

Clinical

Trials by Indication[1]

Vaccine Response2 trials

Systems Biological Assessment of Statin Effect on Vaccine Responses

Completed·EEmory University·Phase 4·NCT06024096·63 enrolled

Systems Biological Assessment of the Durability of Vaccine Responses

Recruiting·EEmory University·Approved·NCT05801978·66 enrolled

Immune Response1 trial

Safety and Immune Response of One Dose of OVX836 at Two Dose Levels, in Comparison to Influvac TetraTM, After Intramuscular Administration in Healthy Subjects Aged 18-65 Years

Completed·OOsivax·Phase 2·NCT04192500·300 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Quadrivalent seasonal influenza vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Quadrivalent seasonal influenza vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Quadrivalent seasonal influenza vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Emory University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Phase 3[1]
Company: EEmory University

Quadrivalent seasonal influenza vaccine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Vaccine Response2 trials

Immune Response1 trial

References

Drug Info

Quick Facts

Related News